CapsoVision, Inc (CV) IPO — S-1 Filing, Stock & Insider Activity

CapsoVision, Inc IPO — Status & S-1 Filing

Ticker: CV
Status: Registered — S-1 filed with the SEC
S-1 filed: 2026-04-17
Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
SEC CIK: 0001378325 · View the S-1 on SEC EDGAR →

Track every registration update on the InsiderAlpha IPO tracker.

Updated Jul 16, 2026 · Last SEC filing 2026-07-11

CapsoVision, Inc (CV) has filed 13 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-11. 3 Form 8-K material event filings were reported by CV in the last 90 days. InsiderAlpha tracks every CV SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About CapsoVision, Inc (CV)

SIC classification	Electromedical & Electrotherapeutic Apparatus (SIC 3845)
SEC CIK	0001378325

90-Day SEC Filing Activity

Form 4 filings (90d)	13
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-07-11

Recent CV Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-07-08	HARARI ELIYAHOU ET AL	10% Owner	P — Open-market purchase	81.3K	$6.09	$495K	SEC
2026-06-30	Tsai Chen Lung	Director	M — Option exercise	2.0K	$7.58	$15K	SEC
2026-06-30	King Wen-Herng Henry	Director	M — Option exercise	2.0K	$7.58	$15K	SEC
2026-06-30	Kuo Hui Ying	Director	M — Option exercise	2.0K	$7.58	$15K	SEC
2026-06-30	Imperial Joanne Carol	Director	M — Option exercise	2.0K	$7.58	$15K	SEC
2026-06-30	GOUW JULIA S	Director	M — Option exercise	2.0K	$7.58	$15K	SEC
2026-06-30	Harari Michele	Director	M — Option exercise	2.0K	$7.58	$15K	SEC
2026-06-26	HARARI ELIYAHOU ET AL	10% Owner	P — Open-market purchase	13.8K	$7.35	$102K	SEC
2026-05-05	Atkinson Douglas Patrick	Head of Global Sales	M — Option exercise	34.8K	$0.57	$20K	SEC
2026-05-04	Atkinson Douglas Patrick	Head of Global Sales	M — Option exercise	30.0K	$0.37	$11K	SEC
2026-05-04	Atkinson Douglas Patrick	Head of Global Sales	M — Option exercise	36.0K	$0.29	$10K	SEC
2026-05-04	Atkinson Douglas Patrick	Head of Global Sales	M — Option exercise	6.5K	$0.57	$4K	SEC
2025-08-18	Petersen Rebecca Ann	Director of Clinical Affairs	M — Option exercise	24.8K	$0.37	$9K	SEC
2025-07-03	Tsai Chen Lung	Director	P — Open-market purchase	20	$4.17	$83	SEC
2025-07-03	Wang Kang-Huai	See Remarks	J — Other acquisition / disposition	446.9K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for CapsoVision, Inc (CV). Updated in real time as new filings are submitted to the SEC.

Most-Active CV Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Atkinson Douglas Patrick	9	$45K
Tsai Chen Lung	2	$15K
GOUW JULIA S	2	$15K
Kuo Hui Ying	2	$15K
HARARI ELIYAHOU ET AL	2	$597K

Recent CV Form 8-K Material Events

2026-07-02 — Item 5.02, 7.01 [SEC]
2026-06-12 — Item 5.07 [SEC]
2026-05-14 — Item 2.02, 9.01 [SEC]
2026-03-26 — Item 2.02, 9.01 · Earnings · neutral [SEC]
CapsoVision, Inc. issued a press release on March 26, 2026 announcing its financial results for the fiscal year ended December 31, 2025. The filing provides standard annual financial results without explicit beat/miss or guidance language.
2026-03-20 — Item 1.01, 2.02, 3.02, 7.01, 8.01, 9.01 · Financing · neutral [SEC]
CapsoVision completed a private placement on March 16, 2026, raising approximately $14 million in gross proceeds by issuing 2,867,089 shares of common stock at $4.883 per share (a 5% discount to closing price). The company intends to use net proceeds for general corporate purpose

Recent Insider Filings

2026-07-11 — HARARI ELIYAHOU ET AL (10% Owner)
2026-07-08 — HARARI ELIYAHOU ET AL (10% Owner)
2026-07-02 — Shields David Stanley (Director)
2026-07-02 — Imperial Joanne Carol (Director)
2026-07-02 — Tsai Chen Lung (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CV insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

CV Insider Trading — FAQ

What is the latest insider trade for CV?: CapsoVision, Inc (CV) had 13 insider filings in the last 90 days, with the most recent on 2026-07-11. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CV stock?: 0 insider purchases of CV were filed in the last 90 days.
How many insiders are selling CV stock?: 0 insider sales of CV were filed in the last 90 days.
Where can I see CV SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every CV SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live CV dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.